The 39 references in paper E. Anaev Kh., K. Fedorchenko Yu., M. Kushaeva E., A. Ryabokon' M., A. Kononikhin S., V. Barmin V., O. Pikin V., I. Popov A., E. Nikolaev N., S. Varfolomeev D., A. Chuchalin G., Э. Анаев Х., К. Федорченко Ю., М. Кушаева Э., А. Рябоконь М., А. Кононихин С., В. Бармин В., О. Пикин В., И. Попов А., Е. Николаев Н., С. Варфоломеев Д., А. Чучалин Г. (2017) “Диагностика заболеваний легких на основе протеомного анализа конденсата выдыхаемого воздуха // Diagnosis of respiratory diseases using the proteomic analysis of exhaled breath condensate” / spz:neicon:pulmonology:y:2017:i:2:p:187-197

1
Konstantinidi E.M., Lappas A.S., Tzortzi A.S., Behrakis P.K. Exhaled Breath Condensate: Technical and Diagnostic Aspects.Scientific World Journal. 2015; 2015: 435160. DOI: 10.1155/2015/435160.
(check this in PDF content)
2
Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486. DOI: 10.1183/09031936.00116107.
(check this in PDF content)
3
Bloemen K., Hooyberghs J., Desager K. et al. Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin. Appl. 2009; 3 (4): 498–504. DOI: 10.1002/prca.200800095. Пульмонология. 2017; 27 (2): 187–197. DOI: 10.18093/086930189320173273231873197
(check this in PDF content)
4
Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Exp. Rev. Proteomics. 2010; 7 (3): 361–372. DOI: 10.1586/epr.10.9.
(check this in PDF content)
5
Lim M.Y., Thomas P.S. Biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer. Int. J. Chronic Dis.2013; 2013: 578613. DOI: 10.1155/2013/578613.
(check this in PDF content)
6
Nobakht M. Gh B.F., Aliannejad R., Rezaei-Tavirani M. et al. The metabolomics of airway diseases, including COPD, asthma and cystic fibrosis. Biomarkers. 2015; 20 (1): 5–16. DOI: 10.3109/1354750X.2014.983167.
(check this in PDF content)
7
Terracciano R., Pelaia G., PreianòM., Savino R. Asthma and COPD proteomics: current approaches and future directions. Proteomics Clin. Appl.2015; 9 (1–2): 203–220. DOI: 10.1002/prca.201400099.
(check this in PDF content)
8
Czitrovszky A., Szymanski W., Nagy A., Jani P. A new method for the simultaneous measurement of particle size, complex refractive index and particle density. Meas Sci. Technol. 2002; 13: 303–308.
(check this in PDF content)
9
Horvath I., Lazar Z., Gyulai N. et al. Exhaled biomarkers in lung cancer.Eur. Respir. J.2009; 34 (1): 261–275. DOI:
(check this in PDF content)
10
1183/09031936.00142508. 10. Lee Y.T., Chen S.C., Shyu L.Y. et al. Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.Clin. Chim. Acta. 2012; 413 (5–6): 630–635. DOI: 10.1016/j.cca.2011.12.010.
(check this in PDF content)
11
Buszewski B., Kesy M., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases.Biomed Chromatogr. 2007; 21 (6): 553–566.
(check this in PDF content)
12
Conrad D.H., Goyette J., Thomas P.S. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.J. Gen. Intern. Med. 2008; 23 (Suppl. 1): 78–84. DOI: 10.1007/s11606-007-0411-1.
(check this in PDF content)
13
Horvath I., Hunt J., Barnes P.J. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 2005; 26 (3): 523–548.
(check this in PDF content)
14
Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2014 года. Доступно на: http://goldcopd. org/wp-content/uploads/2016/04/GOLD_Report_Russian_ 2014.pdf
(check this in PDF content)
15
Чучалин А.Г., Синопальников А.И., Козлов Р.С. и др. Российское респираторное общество (РРО). Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ). Клинические рекомендации по диагностике, лечению и профилактике тяжелой внебольничной пневмонии у взрослых. Пульмонология. 2014; (4): 13–48.
(check this in PDF content)
16
Бычков М.Б., Горбунова В.А. Ассоциация онкологов России. Клинические рекомендации по диагностике и лечению больных раком легкого. М.; 2014. Доступно на:http://oncology-association.ru/docs/recomend/may2015/ 19vz-rek.pdf
(check this in PDF content)
17
Kurova V., Anaev E., Kononikhin A. et al. Proteomics of exhaled breath: methodological nuances and pitfalls.Clin. Chem. Lab. Med. 2009; 47 (6): 706–712. DOI: 10.1515/ CCLM.2009.166.
(check this in PDF content)
18
Ishihama Y., Rappsilber J., Andersen J.S., Mann M. Microcolumns with self-assembled particle frits for proteomics.J. Chromatogr. A.2002; 979 (1–2): 233–239.
(check this in PDF content)
19
Nesvizhskii A., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem.2003; 75 (17): 4646–4658.
(check this in PDF content)
20
Hoffmann H., Tabaksblat L., Enghild J., Dahl R. Human skin keratins are the major proteins in exhaled breath condensate.Eur. Respir. J.2008; 31 (2): 380–384. DOI: 10.1183/09031936.00059707.
(check this in PDF content)
21
Schittek B., Hipfel R., Sauer B. et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2001; 2 (12): 1133–1137.
(check this in PDF content)
22
Ghosh R., Maji U.K., Bhattacharya R., Sinha A.K. The role of dermcidin isoform 2: a two-faceted atherosclerotic risk factor for coronary artery disease and the effect of acetyl salicylic acid on it. Thrombosis. 2012; 2012: 987932. DOI: 10.1155/2012/987932.
(check this in PDF content)
23
Lee Motoyama J.P., Kim-Motoyama H., Kim P. et al. Identification of dermcidin in human gestational tissue and characterization of its proteolytic activity. Biochem. Biophys. Res. Commun. 2007; 35 7(4): 828–833.
(check this in PDF content)
24
Cunningham T.J., Hodge L., Speicher D. et al. Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J. Neurosci.1998; 18: 7047–7060.
(check this in PDF content)
25
Stewart G.D., Skipworth R.J., Pennington C.J. et al. Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines. Br. J. Cancer. 2008; 99 (1): 126–132. DOI: 10.1038/ sj.bjc.6604458.
(check this in PDF content)
26
Yano C.L., Ventrucci G., Field W.N. et al. Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes. BMC Cancer. 2008; 8: 24. DOI: 10.1186/1471-2407-8-24.
(check this in PDF content)
27
Urade Y., Hayaishi O. Prostaglandin D synthase: Structure and function. Vitam. Horm. 2000; 58: 89–120.
(check this in PDF content)
28
Mizon C., Piva F., Queyrel V. et al. Urinary bikunin determination provides insight into proteinase / proteinase inhibitor imbalance in patients with inflammatory diseases. Clin. Chem. Lab. Med.2002; 40 (6): 579–586.
(check this in PDF content)
29
Leclerc E.A., Gazeilles L., Serre G. et al. The ubiquitous dermokine delta activates Rab5 function in the early endocytic pathway. PLoS One.2011; 6 (3): e17816. DOI: 10.1371/ journal.pone.0017816.
(check this in PDF content)
30
Hasegawa M., Higashi K., Yokoyama C. et al. Altered expression of dermokine in skin disorders. J. Eur. Acad. Dermatol. Venereol.2013; 27 (7): 867–875. DOI: 10.1111/ j.1468-3083.2012.04598.x.
(check this in PDF content)
31
Kinnula V.L., Vuorinen K., Ilumets H. et al. Thiol proteins, redox modulation and parenchymal lung disease. Curr. Med. Chem. 2007; 14 (2): 213–222.
(check this in PDF content)
32
Poschmann G., Sitek B., Sipos B. et al. Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell Proteomics. 2009; 8 (5): 1105–1116. DOI: 10.1074/mcp.M800422MCP200.
(check this in PDF content)
33
Spik I., Brenuchon C., Angeli V. et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse.J. Immunol.2005; 174 (6): 3703–3708.
(check this in PDF content)
34
Wei N., Deng X.W. The COP9 signalosome. Annu. Rev. Cell Dev. Biol.2003; 19: 261–286. DOI:10.1146/annurev.cellbio. 19.111301.112449.
(check this in PDF content)
35
Wang Q., Li X., Ren S. et al. Serum levels of the cancertestis antigen POTEE and its clinical significance in nonsmall-cell lung cancer.PLoS One.2015; 10 (4): e0122792. DOI: 10.1371/journal.pone.0122792.
(check this in PDF content)
36
Wood L., Maher J., Bunton T., Resar L. The oncogenic properties of the HMG-I gene family. Cancer Res.2000; 60 (15): 4256–4261. http:// journal.pulmonology.ru/pulm
(check this in PDF content)
37
Resar L. The high mobility group A1 gene: transforming 1. Konstantinidi E.M., Lappas A.S., Tzortzi A.S., Behrakis P.K. Exhaled Breath Condensate: Technical and Diagnostic Aspects.Scientific World Journal. 2015; 2015: 435160. DOI: 10.1155/2015/435160. 2. Borrill Z.L., Roy K., Singh D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J. 2008; 32 (2): 472–486. DOI: 10.1183/09031936.00116107. 3. Bloemen K., Hooyberghs J., Desager K. et al. Non-invasive biomarker sampling and analysis of the exhaled breath proteome. Proteomics Clin. Appl. 2009; 3 (4): 498–504. DOI: 10.1002/prca.200800095. 4. Lin J.L., Bonnichsen M.H., Nogeh E.U. et al. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Exp. Rev. Proteomics. 201
(check this in PDF content)
38
Walmer D., Padin C., Wrona M. et al. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Cancer Res.1995; 55: 1168–1175.
(check this in PDF content)
39
Ziolkowski P., Wozniak M., Dus K., Wisniewski J. The NUCKS: A novel tumor biomarker.J. Mol. Biomark. Diagn. 2013; 4 (145): 1000145. Поступила 31.01.17
(check this in PDF content)